Halozyme Therapeutics shares owned by HPM Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by HPM Partners
from 13F filings
Historical chart of HPM Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by HPM Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26M | 348k | 73.34 |
| 2025-06-30 | $17M | 326k | 52.02 |
| 2025-03-31 | $19M | 291k | 63.81 |
| 2024-12-31 | $16M | 335k | 48.85 |
| 2024-09-30 | $17M | 300k | 57.24 |
| 2024-06-30 | $15M | 291k | 52.36 |
| 2024-03-31 | $12M | 296k | 40.68 |
| 2023-12-31 | $10M | 270k | 36.96 |
| 2023-09-30 | $9.7M | 253k | 38.20 |
| 2023-06-30 | $9.3M | 258k | 36.07 |
| 2023-03-31 | $9.8M | 256k | 38.19 |
| 2022-12-31 | $15M | 259k | 56.90 |
| 2022-09-30 | $265k | 6.7k | 39.55 |
| 2022-06-30 | $262k | 6.0k | 44.01 |